Covington Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.23M | Buy |
15,211
+433
| +3% | +$38.9K | 0.05% | 206 |
|
|
2022
Q2 | $1.33M | Sell |
14,778
-668
| -4% | -$67.7K | 0.05% | 208 |
|
|
2022
Q1 | $1.71M | Sell |
15,446
-24
| -0.2% | -$2.54K | 0.06% | 194 |
|
|
2021
Q4 | $1.6M | Sell |
15,470
-687
| -4% | -$79.6K | 0.06% | 198 |
|
|
2021
Q3 | $2.02M | Buy |
16,157
+25
| +0.2% | +$3.24K | 0.08% | 183 |
|
|
2021
Q2 | $2M | Buy |
16,132
+824
| +5% | +$103K | 0.08% | 184 |
|
|
2021
Q1 | $1.81M | Sell |
15,308
-297
| -2% | -$34.8K | 0.08% | 183 |
|
|
2020
Q4 | $1.83M | Sell |
15,605
-45
| -0.3% | -$4.95K | 0.08% | 172 |
|
|
2020
Q3 | $1.63M | Sell |
15,650
-1,520
| -9% | -$153K | 0.08% | 169 |
|
|
2020
Q2 | $1.57M | Buy |
17,170
+1,301
| +8% | +$125K | 0.09% | 164 |
|
|
2020
Q1 | $1.43M | Buy |
15,869
+7
| +0% | +$745 | 0.09% | 159 |
|
|
2019
Q4 | $1.8M | Buy |
15,862
+177
| +1% | +$19.4K | 0.09% | 156 |
|
|
2019
Q3 | $1.7M | Buy |
15,685
+157
| +1% | +$16.4K | 0.1% | 153 |
|
|
2019
Q2 | $1.51M | Sell |
15,528
-250
| -2% | -$22.8K | 0.09% | 162 |
|
|
2019
Q1 | $1.44M | Sell |
15,778
-550
| -3% | -$49.2K | 0.09% | 157 |
|
|
2018
Q4 | $1.49M | Buy |
16,328
+588
| +4% | +$54.9K | 0.1% | 147 |
|
|
2018
Q3 | $1.55M | Sell |
15,740
-2,699
| -15% | -$250K | 0.09% | 154 |
|
|
2018
Q2 | $1.58M | Sell |
18,439
-396
| -2% | -$33.1K | 0.1% | 154 |
|
|
2018
Q1 | $1.51M | Sell |
18,835
-185
| -1% | -$15.3K | 0.1% | 152 |
|
|
2017
Q4 | $1.54M | Sell |
19,020
-138
| -0.7% | -$11.1K | 0.09% | 154 |
|
|
2017
Q3 | $1.49M | Sell |
19,158
-500
| -3% | -$41.5K | 0.1% | 153 |
|
|
2017
Q2 | $1.75M | Sell |
19,658
-440
| -2% | -$37.1K | 0.14% | 129 |
|
|
2017
Q1 | $1.62M | Sell |
20,098
-777
| -4% | -$60.7K | 0.14% | 131 |
|
|
2016
Q4 | $1.49M | Sell |
20,875
-15,562
| -43% | -$1.22M | 0.13% | 132 |
|
|
2016
Q3 | $3.15M | Sell |
36,437
-1,123
| -3% | -$97.9K | 0.29% | 102 |
|
|
2016
Q2 | $3.26M | Sell |
37,560
-1,674
| -4% | -$135K | 0.3% | 101 |
|
|
2016
Q1 | $2.94M | Sell |
39,234
-1,002
| -2% | -$75.5K | 0.28% | 100 |
|
|
2015
Q4 | $3.1M | Sell |
40,236
-986
| -2% | -$74.2K | 0.3% | 99 |
|
|
2015
Q3 | $2.76M | Sell |
41,222
-5,191
| -11% | -$382K | 0.28% | 103 |
|
|
2015
Q2 | $3.44M | Sell |
46,413
-1,950
| -4% | -$149K | 0.31% | 97 |
|
|
2015
Q1 | $3.77M | Buy |
48,363
+3,163
| +7% | +$240K | 0.36% | 85 |
|
|
2014
Q4 | $3.26M | Sell |
45,200
-1,661
| -4% | -$115K | 0.29% | 98 |
|
|
2014
Q3 | $2.9M | Sell |
46,861
-1,975
| -4% | -$126K | 0.27% | 105 |
|
|
2014
Q2 | $3.15M | Sell |
48,836
-51,398
| -51% | -$3.12M | 0.29% | 102 |
|
|
2014
Q1 | $6.17M | Buy |
100,234
+699
| +0.7% | +$40.7K | 0.6% | 61 |
|
|
2013
Q4 | $5.71M | Buy |
99,535
+4,022
| +4% | +$228K | 0.58% | 65 |
|
|
2013
Q3 | $5.09M | Buy |
95,513
+7,253
| +8% | +$390K | 0.58% | 65 |
|
|
2013
Q2 | $4.54M | Buy |
+88,260
| New | +$4.36M | 0.56% | 65 |
|
Other funds holding MDT
Covington Capital Management's MDT Position: Q3 2022 in Review
Covington Capital Management increased its Medtronic (MDT) stake by 2.9% in Q3 2022, buying an estimated $38.9K and bringing the position to 15,211 shares worth $1.23M. The position accounts for 0.05% of the portfolio, ranked #206.
Covington Capital Management first reported a position in MDT in Q2 2013 and has held it in 38 quarters since. The position peaked at $6.17M in Q1 2014. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Covington Capital Management held 15,211 shares of Medtronic worth $1.23M as of Q3 2022.
- Covington Capital Management bought 433 Medtronic shares in Q3 2022, an estimated $38.9K.
- Medtronic made up 0.05% of Covington Capital Management's portfolio in Q3 2022, its #206 holding.
- Covington Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Medtronic position peaked at $6.17M in Q1 2014.
- 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.